These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34502556)

  • 21. PTH regulation of c-Jun terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats.
    Buzzi N; Boland R; de Boland AR
    Biogerontology; 2007 Apr; 8(2):189-99. PubMed ID: 17120084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.
    Szczepankiewicz BG; Kosogof C; Nelson LT; Liu G; Liu B; Zhao H; Serby MD; Xin Z; Liu M; Gum RJ; Haasch DL; Wang S; Clampit JE; Johnson EF; Lubben TH; Stashko MA; Olejniczak ET; Sun C; Dorwin SA; Haskins K; Abad-Zapatero C; Fry EH; Hutchins CW; Sham HL; Rondinone CM; Trevillyan JM
    J Med Chem; 2006 Jun; 49(12):3563-80. PubMed ID: 16759099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic.
    Qin X; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X
    Mol Carcinog; 2014 Jul; 53(7):526-36. PubMed ID: 23359384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells.
    Zhang XY; Wu XQ; Deng R; Sun T; Feng GK; Zhu XF
    Cell Signal; 2013 Jan; 25(1):150-8. PubMed ID: 22982090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The c-Jun N-terminal kinase pathway and apoptotic signaling (review).
    Chen YR; Tan TH
    Int J Oncol; 2000 Apr; 16(4):651-62. PubMed ID: 10717232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
    Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
    Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells.
    Glotin AL; Calipel A; Brossas JY; Faussat AM; Tréton J; Mascarelli F
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4614-23. PubMed ID: 17003459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
    Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
    Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
    de Lemos L; Junyent F; Camins A; Castro-Torres RD; Folch J; Olloquequi J; Beas-Zarate C; Verdaguer E; Auladell C
    Mol Neurobiol; 2018 May; 55(5):4437-4452. PubMed ID: 28664455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells.
    Dreskin SC; Thomas GW; Dale SN; Heasley LE
    J Immunol; 2001 May; 166(9):5646-53. PubMed ID: 11313405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Jun N-terminal kinase 3 deficiency protects neurons from axotomy-induced death in vivo through mechanisms independent of c-Jun phosphorylation.
    Keramaris E; Vanderluit JL; Bahadori M; Mousavi K; Davis RJ; Flavell R; Slack RS; Park DS
    J Biol Chem; 2005 Jan; 280(2):1132-41. PubMed ID: 15528206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Cho YY; Bode AM; Vummenthala A; Park JG; Liu K; Pang YP; Dong Z
    FEBS Lett; 2009 Jul; 583(13):2208-12. PubMed ID: 19527717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase.
    Namgung U; Xia Z
    J Neurosci; 2000 Sep; 20(17):6442-51. PubMed ID: 10964950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.
    Zhu Y; Shuai W; Zhao M; Pan X; Pei J; Wu Y; Bu F; Wang A; Ouyang L; Wang G
    J Med Chem; 2022 Mar; 65(5):3758-3775. PubMed ID: 35200035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis induced by domoic acid in mouse cerebellar granule neurons involves activation of p38 and JNK MAP kinases.
    Giordano G; Klintworth HM; Kavanagh TJ; Costa LG
    Neurochem Int; 2008 May; 52(6):1100-5. PubMed ID: 18164102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophosphorylation properties of inactive and active JNK2.
    Pimienta G; Ficarro SB; Gutierrez GJ; Bhoumik A; Peters EC; Ronai Z; Pascual J
    Cell Cycle; 2007 Jul; 6(14):1762-71. PubMed ID: 17637567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.
    Sherrin T; Blank T; Hippel C; Rayner M; Davis RJ; Todorovic C
    J Neurosci; 2010 Oct; 30(40):13348-61. PubMed ID: 20926661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.